Yatin Mundkur focuses on early-stage Technology and Medtech investments. As a Partner of Artiman Ventures, he is currently on the boards of Cellworks, Prysm, Virsec, Yantra and zSpace. Yatin holds an impressive 14 patents in areas of computer architectures, digital consumer electronics, semiconductor design, and software.
Cellworks is a life sciences technology company that improves clinical outcomes and creates value for pharma, payors and physicians. Cellworks does this through computational modeling, simulation and annotation of tumor genomics for clinical therapeutics predictions.